CIK 0001613103 · Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- operating
- Phone
- 01135314381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-27 | DONNELLY SCOTT C Director | Grant or award | +2,111 | 23,886 | ||
| 2026-04-27 | Jellison William R Director | Grant or award | +1,444 | 6,444 | ||
| 2026-04-27 | HOGAN RANDALL J Director | Grant or award | +2,111 | 49,205 | ||
| 2026-04-27 | ARNOLD CRAIG Director | Grant or award | +2,111 | 42,392 | ||
| 2026-03-03 | Pieton Thierry EVP & Chief Financial Officer | Shares withheld for taxes | −2,976 | $96.71 | $288K | 37,574 |
| 2026-02-20 | Blomquist Denise L. Chief Accounting Officer | Gift | −340 | 11,966 | ||
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Option exercise | +30,568 | $93.08 | $2.8M | 64,984 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Option exercise | +19,923 | $87.76 | $1.7M | 84,907 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Option exercise | +385 | $80.00 | $31K | 85,292 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Sale | −1,648 | $97.86 | $161K | 83,644 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Sale | −30,568 | $97.66 | $3.0M | 53,076 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Sale | −19,255 | $97.77 | $1.9M | 33,821 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Sale | −668 | $97.83 | $65K | 33,153 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Sale | −385 | $97.82 | $38K | 32,768 |
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Option exercise · Stock Option (Right to Buy) | −30,568 | 11,606 | ||
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Option exercise · Stock Option (Right to Buy) | −19,923 | 18,926 | ||
| 2026-02-19 | KIIL HARRY SKIP EVP & President Cardiovascular | Option exercise · Stock Option (Right to Buy) | −385 | 1,155 | ||
| 2026-01-29 | Blomquist Denise L. Chief Accounting Officer | Shares withheld for taxes | −148 | $101.00 | $15K | 12,306 |
| 2025-12-15 | Marinaro Michael EVP, Pres MedSurg and Americas | Shares withheld for taxes | −1,371 | $99.87 | $137K | 50,818 |
| 2025-12-15 | Martha Geoffrey Chairman and CEO | Shares withheld for taxes | −1,564 | $99.87 | $156K | 246,393 |
Page 5 of 12 · 239 trades